For example, some allelic variants of the melanocortin 1 receptor (MC1R) can act as genetic modifiers by increasing the penetrance of cyclin-dependent kinase inhibitor 2A (CDKN2A) mutations, doubling the risk of melanoma compared to those only harboring the CDKN2A mutation [9]. Here, CDKN2A is linked to melanoma.